292 related articles for article (PubMed ID: 32990512)
1. Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-enhanced MRI for Predicting Microvascular Invasion in Hepatocellular Carcinoma.
Min JH; Lee MW; Park HS; Lee DH; Park HJ; Lim S; Choi SY; Lee J; Lee JE; Ha SY; Cha DI; Carriere KC; Ahn JH
Radiology; 2020 Dec; 297(3):573-581. PubMed ID: 32990512
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric assessment of microvascular invasion in hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
Fujita N; Ushijima Y; Ishimatsu K; Okamoto D; Wada N; Takao S; Murayama R; Itoyama M; Harada N; Maehara J; Oda Y; Ishigami K; Nishie A
Abdom Radiol (NY); 2024 May; 49(5):1467-1478. PubMed ID: 38360959
[TBL] [Abstract][Full Text] [Related]
3. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma.
Lee S; Kim SH; Lee JE; Sinn DH; Park CK
J Hepatol; 2017 Sep; 67(3):526-534. PubMed ID: 28483680
[TBL] [Abstract][Full Text] [Related]
4. Nomogram for Predicting Microvascular Invasion in Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced MRI and Intravoxel Incoherent Motion Imaging.
Zhou L; Qu Y; Quan G; Zuo H; Liu M
Acad Radiol; 2024 Feb; 31(2):457-466. PubMed ID: 37491178
[TBL] [Abstract][Full Text] [Related]
5. Prediction of HCC microvascular invasion with gadobenate-enhanced MRI: correlation with pathology.
Zhang L; Yu X; Wei W; Pan X; Lu L; Xia J; Zheng W; Jia N; Huo L
Eur Radiol; 2020 Oct; 30(10):5327-5336. PubMed ID: 32367417
[TBL] [Abstract][Full Text] [Related]
6. Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and (18)F-FDG PET/CT.
Ahn SY; Lee JM; Joo I; Lee ES; Lee SJ; Cheon GJ; Han JK; Choi BI
Abdom Imaging; 2015 Apr; 40(4):843-51. PubMed ID: 25253426
[TBL] [Abstract][Full Text] [Related]
7. Imaging features of small hepatocellular carcinomas with microvascular invasion on gadoxetic acid-enhanced MR imaging.
Kim MJ; Lee M; Choi JY; Park YN
Eur J Radiol; 2012 Oct; 81(10):2507-12. PubMed ID: 22137613
[TBL] [Abstract][Full Text] [Related]
8. Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images.
Kim KA; Kim MJ; Jeon HM; Kim KS; Choi JS; Ahn SH; Cha SJ; Chung YE
J Magn Reson Imaging; 2012 Mar; 35(3):629-34. PubMed ID: 22069244
[TBL] [Abstract][Full Text] [Related]
9. Direct Comparison of Four Presurgical Stratifying Schemes for Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Gadoxetic Acid-Enhanced MRI.
Sun SW; Liu QP; Xu X; Zhu FP; Zhang YD; Liu XS
J Magn Reson Imaging; 2020 Aug; 52(2):433-447. PubMed ID: 31943465
[TBL] [Abstract][Full Text] [Related]
10. Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging: Impact of intra-tumoral fat detected on chemical-shift images.
Min JH; Kim YK; Lim S; Jeong WK; Choi D; Lee WJ
Eur J Radiol; 2015 Jun; 84(6):1036-43. PubMed ID: 25818729
[TBL] [Abstract][Full Text] [Related]
11. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
12. IVIM improves preoperative assessment of microvascular invasion in HCC.
Wei Y; Huang Z; Tang H; Deng L; Yuan Y; Li J; Wu D; Wei X; Song B
Eur Radiol; 2019 Oct; 29(10):5403-5414. PubMed ID: 30877465
[TBL] [Abstract][Full Text] [Related]
13. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
[TBL] [Abstract][Full Text] [Related]
14. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Performance of Gadoxetic Acid Disodium MRI in Predicting Microvascular Invasion of Hepatocellular Carcinoma.
Chen J; Ming X; Wang Z; Ye Y
Contrast Media Mol Imaging; 2022; 2022():6128845. PubMed ID: 36247863
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MR imaging can predict early recurrence after curative resection using image features and texture analysis.
Ahn SJ; Kim JH; Park SJ; Kim ST; Han JK
Abdom Radiol (NY); 2019 Feb; 44(2):539-548. PubMed ID: 30229421
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
[TBL] [Abstract][Full Text] [Related]
18. Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma?
Renzulli M; Brocchi S; Cucchetti A; Mazzotti F; Mosconi C; Sportoletti C; Brandi G; Pinna AD; Golfieri R
Radiology; 2016 May; 279(2):432-42. PubMed ID: 26653683
[TBL] [Abstract][Full Text] [Related]
19. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.
Chou YC; Lao IH; Hsieh PL; Su YY; Mak CW; Sun DP; Sheu MJ; Kuo HT; Chen TJ; Ho CH; Kuo YT
World J Gastroenterol; 2019 Jun; 25(21):2636-2649. PubMed ID: 31210715
[TBL] [Abstract][Full Text] [Related]
20. Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
Lee S; Kim KW; Jeong WK; Kim MJ; Choi GH; Choi JS; Song GW; Lee SG
Eur Radiol; 2020 Feb; 30(2):987-995. PubMed ID: 31471754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
